Tallinn-based medtech Nanordica Medical raises €1.75 million to treat severe wounds with nanotechnology

Published on May 16, 2024

Estonian medtech company Nanordica Medical has raised €1.75 million to enter the market with first-in-class wound care products curing severe wounds. The round was led by Estonian fund Specialist VC, with participation from Superangel and Amalfi. 100 million patients suffer from chronic wounds such as diabetic foot, venous leg and pressure ulcers. Moreover, the prevalence…

This content is for members only. Visit the site and log in/register to read.

The post Tallinn-based medtech Nanordica Medical raises €1.75 million to treat severe wounds with nanotechnology appeared first on EU-Startups.

Continue reading on website
Other news

London-based Native Teams raises €6.2 million to advance remuneration for the new world of work

May 16, 2024
Native Teams, a work payments platform for freelancers, remote workers, and business owners, has successfully raised a further round of investment totalling €6.275 million to power its ambitious plans of becoming the go-to platform for work payments. The startup received support from existing investors Eleven Ventures and Fil Rouge Capital and new investors MFG Invest,… This content is for members

French biotech HEPHAISTOS-Pharma gets €4.5 million to develop next-gen of immunostimulants against cancer

May 16, 2024
HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer targeting innate immunity to increase the cure rate of patients, has completed its €4.5 million seed round to finance industrialization and advance its lead candidate ONCO-Boost towards the clinic. Elaia leads a consortium previously initiated by xista science ventures, the Fondation Fournier-Majoi